Welcome to our weekly roundup of CBD and hemp-related legal and regulatory news:
A review, published in the Annals of Internal Medicine and funded by the HHS, found that although cannabinoids can be generally helpful for chronic pain, products with a higher THC-to-CBD ratio may be more potent than products with a higher CBD-to-THC ratio. However, the authors said more research is needed to fully understand the long-term impacts of cannabis use, whether it be THC or CBD. Miami Herald.
In a study of CBD products purchased in store and online, 31% were under-labeled, 54% were labeled accurately and 15% were over-labeled. Out of those purchased online, 25% were under-labeled, 61% were labeled accurately and 14% were over-labeled. For the others purchased locally, 39% were under-labeled, 17% were over-labeled and 44% were labeled accurately. The researchers recommend clear regulations from both the federal and state agencies regarding CBD labeling, as well as better manufacturing practices within the industry. NewsMedical.net.
In an important step for clear hemp policy reform, Gov. Tim Walz (D) signed a bill to permanently correct a legislative drafting problem that emerged after state lawmakers sought to align Minn.’s hemp policy with that of the federal government. It will make it so hemp-derived CBD can be legally sold in food items, beverages, topicals and more, as long as the products contain less than the federal limit of 0.3% THC. Edible and beverage products will need to be limited to a total of 5 mg THC per serving and 50 mg per package. Advocates remain disappointed that broader marijuana legalization didn’t advance through the GOP-controlled Senate, despite a recent effort by Democratic leadership to force a vote ahead of a legislative deadline. Marijuana Moment.
In a presentation before the Cleveland School of Cannabis, Homeland Hempcrete founders mixed the hemp hurd-based product and poured it into a short wall frame. The hempcrete serves as an insulative infill in buildings. Cannabis Business Times.
Under the National Organic Program standards, as with any crop, a hemp grower must understand the rules and regulations to be officially considered USDA Organic. Especially important for hemp, processing needs to use approved substances in the manufacturing to be considered organic. The higher cost of organic production comes from higher costs for organic seeds or plants, certification, labor, equipment and fuel. Looking past the monetary aspect, says a hemp extension specialist at Purdue University’s Department of Agronomy, using organic management practices – even for non-certified organic producers – has environmental benefits, but the decision to transition to organic production comes down to the grower and what aligns with their goals and finances. Cannabis Business Times.
A GW Pharmaceuticals motion asks a Calif. federal judge to toss a proposed securities class action alleging the company misled investors to achieve a $7.2-billion acquisition deal. GW argues the purportedly misleading statements at issue were protected by the “safe harbor” provision of the Private Securities Litigation Reform Act, adding they were forward-looking and protected as cautionary language. GW is represented by DLA Piper and Wachtell Lipton Rosen & Katz. Law 360 (sub. req.).
The DEA said federal courts of appeal have exclusive authority to hear cases challenging the AG’s actions under the Administrative Procedures Act, and any injunction granted by the district court would have unintended ramifications. The agency added the affiliated companies that brought the action – MMJ International Holdings, MMJ BioPharma Cultivation and MMJ BioPharma Labs – could refile their action in the U.S. Court of Appeals for D.C. Duane Boise, president of MMJ, argued the DEA’s brief is the latest in a series of delay tactics used by the agency to hamper the lab’s efforts, and said he expects the court to rule in the lab’s favor on the jurisdictional issue. Law 360 (sub. req.).
JARS Cannabis filed the lawsuit in Wayne County Circuit Court, arguing the ordinance violates Mich. law. The company, which operates two medical cannabis dispensaries in Detroit and other medical and adult-use dispensaries elsewhere in the state, is asking the court to block the city from moving ahead with its ordinance. JARS alleges Detroit has created an algorithm to give preferential treatment to its residents, in violation of the state regulator’s framework for legally growing and selling recreational marijuana. In May, a group of medical dispensaries also filed a lawsuit to challenge the city’s revised ordinance. Cannabis Business Times.
U.S. District Judge Thomas L. Ludington found the plaintiffs, Green Stones and Jeffrey Yatooma, didn’t allege an actual or imminent injury and therefore lacked standing to pursue their case. They filed their complaint against Birch Run Township in Apr., claiming some of the town’s criteria for awarding licenses were vague and immaterial, and would prevent them from securing a winning score, despite their years of experience in Mich.’s medical marijuana industry. Law 360 (sub. req.).
* * * *
Find all of our blogs, podcasts, apps, resource centers, and newsletters on our Linktree.